Literature DB >> 32100490

Stage II endometrial cancer requires stratification according to uterine risk factor and sentinel lymph node sampling.

Yung Taek Ouh1, Kyung Jin Min2.   

Abstract

Entities:  

Year:  2020        PMID： 32100490      PMCID： PMC7044012          DOI： 10.3802/jgo.2020.31.e50

Source DB:  PubMed          Journal:  J Gynecol Oncol        ISSN： 2005-0380            Impact factor:   4.401


× No keyword cloud information.
  7 in total

1.  A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.

Authors:  Emma C Rossi; Lynn D Kowalski; Jennifer Scalici; Leigh Cantrell; Kevin Schuler; Rabbie K Hanna; Michael Method; Melissa Ade; Anastasia Ivanova; John F Boggess
Journal:  Lancet Oncol       Date:  2017-02-01       Impact factor: 41.316

2.  Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis.

Authors:  Yukiharu Todo; Hidenori Kato; Masanori Kaneuchi; Hidemichi Watari; Mahito Takeda; Noriaki Sakuragi
Journal:  Lancet       Date:  2010-02-24       Impact factor: 79.321

3.  Quality of life in patients with endometrial cancer treated with or without systematic lymphadenectomy.

Authors:  Roberto Angioli; Francesco Plotti; Ester Valentina Cafà; Nella Dugo; Stella Capriglione; Corrado Terranova; Roberto Montera; Federica Guzzo; Pierluigi Benedetti Panici
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2013-08-07       Impact factor: 2.435

4.  Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?

Authors:  M Takano; H Ochi; Y Takei; M Miyamoto; Y Hasumi; Y Kaneta; K Nakamura; A Kurosaki; T Satoh; H Fujiwara; S Nagao; K Furuya; H Yokota; K Ito; T Minegishi; H Yoshikawa; K Fujiwara; M Suzuki
Journal:  Br J Cancer       Date:  2013-09-03       Impact factor: 7.640

5.  Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial.

Authors:  Stephanie M de Boer; Melanie E Powell; Linda Mileshkin; Dionyssios Katsaros; Paul Bessette; Christine Haie-Meder; Petronella B Ottevanger; Jonathan A Ledermann; Pearly Khaw; Romerai D'Amico; Anthony Fyles; Marie-Helene Baron; Ina M Jürgenliemk-Schulz; Henry C Kitchener; Hans W Nijman; Godfrey Wilson; Susan Brooks; Sergio Gribaudo; Diane Provencher; Chantal Hanzen; Roy F Kruitwagen; Vincent T H B M Smit; Naveena Singh; Viet Do; Andrea Lissoni; Remi A Nout; Amanda Feeney; Karen W Verhoeven-Adema; Hein Putter; Carien L Creutzberg
Journal:  Lancet Oncol       Date:  2019-07-22       Impact factor: 41.316

6.  Survival and recurrence in stage II endometrial cancers in relation to uterine risk stratification after introduction of lymph node resection and omission of postoperative radiotherapy: a Danish Gynecological Cancer Group Study.

Authors:  Gitte Ørtoft; Claus Høgdall; Estrid S Hansen; Margit Dueholm
Journal:  J Gynecol Oncol       Date:  2019-10-04       Impact factor: 4.401

7.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.

Authors:  H Kitchener; A M C Swart; Q Qian; C Amos; M K B Parmar
Journal:  Lancet       Date:  2008-12-16       Impact factor: 79.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.